First-in-class drug approvals
RecordSTO-KNZB8QGH5G-14C6AH9Y1T-332SVW
China · 2024
First-in-class drug approvals in China were 48 in 2024 (NMPA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- NMPA
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
China approved 48 first-in-class innovative drugs, as well as a significant number of medications for pediatric and rare diseases, thanks to measures aimed at enhancing review efficiency and accelerating patient access to novel therapies, according to a report released on Tuesday by the National Medical Products Administration.
Checked: the figure 48is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Medical Products Administration. (2024). Measures facilitate approval of 48 first-in-class innovative drugs. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Via StatOrigin, https://statorigin.org/stat/stat_KNZB8QGH5G14C6AH9Y1T332SVW
Other formats: MLA, Chicago, BibTeX
- MLA
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2024, https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_KNZB8QGH5G14C6AH9Y1T332SVW.
- Chicago
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2024. https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_KNZB8QGH5G14C6AH9Y1T332SVW.
- BibTeX
- @misc{nmpa2024first332svw, author = {{National Medical Products Administration}}, title = {Measures facilitate approval of 48 first-in-class innovative drugs}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_KNZB8QGH5G14C6AH9Y1T332SVW}, note = {Original source: https://english.nmpa.gov.cn/2025-03/21/c\_1080286.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Medical Products Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Measures facilitate approval of 48 first-in-class innovative drugs
- Type
- Press release
- Published
- —
- Locator
- Measures facilitate approval of 48 first-in-class innovative drugs
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_KNZB8QGH5G14C6AH9Y1T332SVW